Humans have been using cannabis for its medicinal properties for thousands of years. Cannabis supplements the body’s natural endocannabinoid system and has been used to treat medical conditions including pain, sleep, anxiety, inflammation, epilepsy and other conditions.
Cannabis contains a number of active compounds, or cannabinoids, that act on endocannabinoid receptors in cells located in the brain, nervous system and elsewhere in the human body. The endocannabinoid system of the human body is involved in many pathways including the regulation of neurotransmitters. These, in turn, regulate other body processes that can impact on things like pain and mood. Some cannabinoids also affect other processes in the body such as inflammation, for example, by acting on COX and PPAR related pathways.
Humans have been using cannabis for its medicinal properties for thousands of years. Cannabis supplements the body’s natural endocannabinoid system and has been used to treat medical conditions including pain, sleep, anxiety, inflammation, epilepsy and other conditions.
Cannabis contains a number of active compounds, or cannabinoids, that act on endocannabinoid receptors in cells located in the brain, nervous system and elsewhere in the human body. The endocannabinoid system of the human body is involved in many pathways including the regulation of neurotransmitters. These, in turn, regulate other body processes that can impact on things like pain and mood. Some cannabinoids also affect other processes in the body such as inflammation, for example, by acting on COX and PPAR related pathways.
The two most prevalent cannabinoids are THC, which is responsible for the euphoric feeling generally resulting from cannabis consumption; and CBD, which has neurological and systemic effects without the intoxicating effect of THC. Both have medicinal benefits, and various formulations of THC and CBD have been investigated in a variety of applications.
Whilst derived from the same plant, CBD as a market is largely focused on the provision of unregulated consumer products such as wellness products, cosmetics and drink supplements. Whereas higher THC cannabinoids are heavily regulated and used for medicinal purposes for the treatment of specific conditions.
The two most prevalent cannabinoids are THC, which is responsible for the euphoric feeling generally resulting from cannabis consumption; and CBD, which has neurological and systemic effects without the intoxicating effect of THC. Both have medicinal benefits, and various formulations of THC and CBD have been investigated in a variety of applications.
Whilst derived from the same plant, CBD as a market is largely focused on the provision of unregulated consumer products such as wellness products, cosmetics and drink supplements. Whereas higher THC cannabinoids are heavily regulated and used for medicinal purposes for the treatment of specific conditions.
Despite legalisation and evidence of efficacy for treatment of chronic pain,
often currently treated by opiods, very few patients are enjoying the benefits of medicinal cannabis legally.
Once Celadon are growing and selling cannabis into the market, many of the problems with product availability should be solved.
When there is consistent supply and delivery methods, Celadon expects to be able to undertake clinical trials and collect valuable data.
Celadon plans to help doctors by giving them clear evidence needed to prescribe. Essential doctor training at it’s training hub will be provided.
As a consequence of providing doctors with training at our newly built out training hub, more doctors are expected to be prescribing cannabis.
Input your search keywords and press Enter.